- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04192786
Local Vibration in Multiple Sclerosis Patients
June 26, 2020 updated by: Fatma Ayvat, Hacettepe University
The Effect of Local Vibration Applied to Spastic Gastrocnemius on Muscle Architecture and Functional Properties in Multiple Sclerosis Patients
Gastrocnemius spasticity is one of the main complaints in Multiple Sclerosis patients.Local muscle vibration is a method used for spasticity inhibition.
However, when the studies in the literature are examined; It is noted that local vibration applications for spasticity are usually single sessions and evaluate the acute effect, do not produce functional outputs, there is no consensus on frequency and amplitude and the changes in muscle architecture are not examined.
In this study, we aimed to investigate the effect of local vibration applied on spastic gastrocnemius on muscle architectural and functional properties in Multiple Sclerosis patients in addition to the standard physiotherapy program.
The study was planned to include 3 groups, 2 treatment and 1 control group.
The control group will receive standard physiotherapy, one of the treatment groups will receive 50 Hz local vibration in addition to standard physiotherapy, and other treatment group will receive 100 Hz local vibration in addition to standard physiotherapy.
Disease severity, gastrocnemius spasticity, architectural and viscoelastic properties of muscle, ankle proprioception, balance and gait skills will be evaluated before and after 8 weeks treatment program.
As a result; effectiveness of local vibration in addition to standard physiotherapy program and whether there is a difference between applications at different frequencies will be examined.
Study Overview
Status
Unknown
Conditions
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Altındağ
-
Ankara, Altındağ, Turkey, 06100
- Recruiting
- Hacettepe University, Faculty of Physical Therapy and Rehabilitation
-
Contact:
- Muhammed Kılınç, Assoc. Prof.
- Phone Number: +905326418381
- Email: muhammedkilinc@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- > 18 years
- EDSS<5,5
- Gastrocnemius spasticity<2
Exclusion Criteria:
- having any injury or surgery of the lower extremity
- having systemic and metabolic disease
- having behavioral and cognitive problems that prevent consistence to guidelines given
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Treatment Group 50 Hz
|
Standard physiotherapy program (strength, balance, gait exercises) for 50 minutes and local vibration applied to gastrocnemius (50 Hz) for 10 minutes will be performed 3 days a week for 8 weeks.
|
|
EXPERIMENTAL: Treatment Group 100 Hz
|
Standard physiotherapy program (strength, balance, gait exercises) for 50 minutes and local vibration applied to gastrocnemius (100 Hz) for 10 minutes will be performed 3 days a week for 8 weeks.
|
|
ACTIVE_COMPARATOR: Control Group
|
Standard physiotherapy program (strength, balance, gait exercises) for 60 minutes will be performed 3 days a week for 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of Muscle Thickness and Fascicle Length with Ultrasonography
Time Frame: 3 minutes
|
Bilateral Medial Gastrocnemius US evaluations were performed with use of a 5-10 MHz linear probe (Diasus Dynamic Imaging Ltd, Livingston, Scotland,UK).
Patients were positioned prone position with their legs and their muscles relaxed for medial gastrocnemius.
Muscle Thickness and Fascicle Length would be expressed as centimeters.
|
3 minutes
|
|
Evaluation of Pennation Angle with Ultrasonography
Time Frame: 2 minutes
|
Bilateral Medial Gastrocnemius US evaluations were performed with use of a 5-10 MHz linear probe (Diasus Dynamic Imaging Ltd, Livingston, Scotland,UK).
Patients were positioned prone position with their legs and their muscles relaxed for medial gastrocnemius.
Pennation Angle would be angularly indicated.
|
2 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of spasticity
Time Frame: 5 minutes
|
Modified Ashworth Scale (minimum score 0 (worse), maximum score 4 (better))
|
5 minutes
|
|
Assessment of viscoelastic properties of muscle
Time Frame: 5 minutes
|
Myoton-3 (assessment of tone, elasticity and stiffness)
|
5 minutes
|
|
Assessment of ankle proprioception
Time Frame: 5 minutes
|
Isokinetic dynamometer (Isomed 2000) (passive ankle joint position sense)
|
5 minutes
|
|
Assessment of single leg balance
Time Frame: 3 minutes
|
Single leg balance test
|
3 minutes
|
|
Assessment of balance
Time Frame: 10 minutes
|
Bertec Balance Check ScreenerTM force platform system (Assessment of limits of stability, anteroposterior and mediolateral sway range)
|
10 minutes
|
|
Assessment of gait characterictics
Time Frame: 5 minutes
|
GAITRite Analysis System (assessment of velocity, step length, percentage of gait cycle spent in double and single support, stance phase, swing phase, base of support)
|
5 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 15, 2019
Primary Completion (ANTICIPATED)
November 1, 2020
Study Completion (ANTICIPATED)
December 1, 2020
Study Registration Dates
First Submitted
November 26, 2019
First Submitted That Met QC Criteria
December 7, 2019
First Posted (ACTUAL)
December 10, 2019
Study Record Updates
Last Update Posted (ACTUAL)
June 30, 2020
Last Update Submitted That Met QC Criteria
June 26, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KA-19018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Standard physiotherapy program+50 Hz local vibration
-
Bitlis Eren UniversityCompleted
-
Dokuz Eylul UniversityRecruitingSubacromial Pain SyndromeTurkey
-
Universidade Federal do Rio Grande do NorteCompletedNeuromuscular Performance and BalanceBrazil
-
Acibadem UniversityNot yet recruitingHealthy Volunteers | Vibration; Adverse EffectTurkey (Türkiye)
-
Universidade Federal do Rio Grande do NorteCompletedAnterior Cruciate Ligament Reconstruction
-
Kutahya Health Sciences UniversityCompleted
-
Cairo UniversityCompleted
-
Marwa Gamal Abd El Ghany FathallaCompletedKnee OsteoarthritisEgypt
-
University of JazanCompletedCoronary Artery Disease | ObesitySaudi Arabia
-
Al Hayah University In CairoRecruitingLong-Term Multidisciplinary Physiotherapy for Breast Cancer Survivors: A Randomized Controlled TrialBreast Cancer | Breast Cancer FemaleEgypt